Valuation: Stereotaxis Inc

Market Cap 133M 115M 107M 98.57M 186M 12.65B 189M 1.27B 495M 6.28B 498M 487M 21.13B P/E 2026 *
-6.65x
P/E 2027 * -8.87x
Enterprise Value 133M 115M 107M 98.57M 186M 12.65B 189M 1.27B 495M 6.28B 498M 487M 21.13B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 2.49x
Free-Float
84.7%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer - 03/02/2017
Director of Finance/CFO 57 01/10/2019
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 79 01/02/2005
Chairman - 03/02/2017
Director/Board Member 71 29/09/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+0.41%+20.40%+4.74% 214B
-0.49%+1.82%-3.91%-23.15% 138B
-0.49%+6.11%-29.61%+8.60% 125B
-0.29%+5.53%-56.92%-11.30% 68.43B
+1.03%+3.58%+6.97%+5.79% 49.38B
-0.91%+9.32%-24.83%-29.57% 47.55B
-1.32%-0.65%+17.61%+14.01% 39.63B
+0.50%-0.22%+27.58%+38.14% 37.26B
-3.28%+12.13%-2.97%-10.88% 32.71B
Average -0.63%+7.11%-5.08%-0.40% 83.56B
Weighted average by Cap. -0.50%+7.53%-3.95%-1.84%

Financials

2026 *2027 *
Net sales 39.4M 34.22M 31.78M 29.31M 55.21M 3.76B 56.21M 376M 147M 1.87B 148M 145M 6.28B 53.28M 46.27M 42.97M 39.63M 74.65M 5.09B 76M 509M 199M 2.53B 200M 196M 8.49B
Net income -19.4M -16.85M -15.65M -14.43M -27.18M -1.85B -27.68M -185M -72.53M -920M -72.85M -71.26M -3.09B -13.62M -11.83M -10.99M -10.14M -19.09M -1.3B -19.44M -130M -50.94M -646M -51.17M -50.05M -2.17B
Net Debt - -
Logo Stereotaxis Inc
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, it offers its customers x-ray systems and other accessory devices. It also provides robotic technologies for interventional cardiology and neuro-interventions. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-